Sanhe Chengxin Xinhang E-commerce Co., Ltd – Trademark Portfolio

Entity Type: 99

Sanhe Chengxin Xinhang E-commerce Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PIPILAKA. The owner is based in Langfang City, Hebei Province.

Room 201, No. 49, Yingbin South Road, Sanhe District

Langfang City, Hebei Province 065200 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PIPILAKA
PIPILAKA
Registered 2025

Trademark Classifications

Sanhe Chengxin Xinhang E-commerce Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Sanhe Chengxin Xinhang E-commerce Co., Ltd have?

Sanhe Chengxin Xinhang E-commerce Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Sanhe Chengxin Xinhang E-commerce Co., Ltd file in?

Sanhe Chengxin Xinhang E-commerce Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Sanhe Chengxin Xinhang E-commerce Co., Ltd's most well-known trademarks?

Sanhe Chengxin Xinhang E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as PIPILAKA. These are among 1 currently registered trademark in the portfolio.

What is Sanhe Chengxin Xinhang E-commerce Co., Ltd's trademark registration success rate?

Sanhe Chengxin Xinhang E-commerce Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.